Does Spravato Help Anxiety? What the Research Actually Shows

About 40 million Americans struggle with anxiety, often despite trying various treatments. This video provides essential mental health education by introducing an anxiety medication approach that targets a different part of the human brain than typical methods. For some, this treatment for generalized anxiety disorder can help how to stop anxiety within hours. 00:00 Anxiety Treatment Gap 00:48 Claudia’s Breakthrough 01:34 Why SSRIs Fall Short 02:23 What Is Spravato 02:59 Glutamate and Neuroplasticity 04:12 Does It Help Anxiety 05:47 Midlife Biology Link 06:49 Who Should Consider It 07:34 Clinic Process and Safety 08:14 The Biggest Mistake 08:35 Using the Plasticity Window 09:18 Wrap Up and Next Steps ========== The Nervous System RESET - https://resetns.com/sales-page FREE SLEEP GUIDE. Download here - https://app.healthpreneurgroup.com/v2... =========== This content is for educational purposes only and does not replace medical advice. Always consult your healthcare provider before starting, stopping, or changing medications, supplements, or treatment plans. If you are suicidal or homicidal, go to the nearest emergency room or call 911. Some of the links in this description may be affiliate links. If you choose to purchase through them, I may earn a small commission at no additional cost to you. I only recommend products and tools that I believe can genuinely support your health and well-being. #anxiety, #anxietyrelief, #howtostopanxiety, #anxietysymptoms, #panicattacks, #howtocalmanxiety, #generalizedanxietydisorder, #anxietytreatment, #anxietyhelp, #nervoussystemregulation ============= If you found this video helpful, please consider liking and subscribing. It genuinely helps the channel and allows me to keep producing evidence-based mental health content. ============= REFERENCES Popova V, et al. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression (TRANSFORM-2). American Journal of Psychiatry. 2019;176(6):428-438. Daly EJ, et al. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression (SUSTAIN-1). JAMA Psychiatry. 2019;76(9):893-903. Jauhar S, Morrison P. Esketamine for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis. American Journal of Psychiatry. 2024. Lamers F, et al. Comorbidity Patterns of Anxiety and Depressive Disorders in a Large Cohort Study: The Netherlands Study of Depression and Anxiety (NESDA). Journal of Clinical Psychiatry. 2011;72(3):341-348. Hartland H, et al. A Transdiagnostic Systematic Review and Meta-Analysis of Ketamine's Anxiolytic Effects. Journal of Psychopharmacology. 2023;37(8):764-774. Masdrakis VG, Tebbs Z, Natsis V, Baldwin DS. Ketamine/Esketamine Pharmacotherapy for Treatment of Anxiety Disorders and Anxiety Symptoms in Depression: Systematic Review. Journal of Psychopharmacology. 2025. Whittaker E, Dadabayev AR, Joshi SA, Glue P. Systematic Review and Meta-Analysis of Randomized Controlled Trials of Ketamine in the Treatment of Refractory Anxiety Spectrum Disorders. Therapeutic Advances in Psychopharmacology. 2021;11. Tully JL, et al. Ketamine Treatment for Refractory Anxiety: A Systematic Review. British Journal of Clinical Pharmacology. 2022;88(10):4412-4426.